Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_1
1
25%
Ph phase_4
1
25%
Ph not_applicable
2
50%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

withdrawn125%
completed250%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_1

Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy

NCT04181255
completedphase_4

Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia

NCT01039285
withdrawnnot_applicable

Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

NCT01537354
completednot_applicable

Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks

NCT00751959

Clinical Trials (4)

Showing 4 of 4 trials
NCT04181255Phase 1

Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy

Terminated
NCT01039285Phase 4

Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia

Completed
NCT01537354Not Applicable

Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

Withdrawn
NCT00751959Not Applicable

Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4